Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, W.
Right arrow Articles by Nawata, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, W.
Right arrow Articles by Nawata, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:1000-1008, 2005
© 2005 by the American Diabetes Association, Inc.

Androgen Receptor Null Male Mice Develop Late-Onset Obesity Caused by Decreased Energy Expenditure and Lipolytic Activity but Show Normal Insulin Sensitivity With High Adiponectin Secretion

WuQiang Fan1, Toshihiko Yanase1, Masatoshi Nomura1, Taijiro Okabe1, Kiminobu Goto1, Takashi Sato2, Hirotaka Kawano2, Shigeaki Kato2, and Hajime Nawata1

1 Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan
2 Institute of Molecular and Cellular Biosciences, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan

Androgen receptor (AR) null male mice (ARL–/Y) revealed late-onset obesity, which was confirmed by computed tomography–based body composition analysis. ARL–/Y mice were euphagic compared with the wild-type male (ARX/Y) controls, but they were also less dynamic and consumed less oxygen. Transcript profiling indicated that ARL–/Y mice had lower transcripts for the thermogenetic uncoupling protein 1, which was subsequently found to be ligand-dependently activated by AR. We also found enhanced secretion of adiponectin, which is insulin sensitizing, from adipose tissue and a relatively lower expression of peroxisome proliferator–activated receptor-{gamma} in white adipose tissue in comparison to ARX/Y mice. Both factors might explain why the overall insulin sensitivity of ARL–/Y mice remained intact, despite their apparent obesity. The results revealed that AR plays important roles in male metabolism by affecting the energy balance, and it is negative to both adiposity and insulin sensitivity.


Address correspondence and reprint requests to Toshihiko Yanase, MD, PhD, Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582 Japan. E-mail: yanase{at}intmed3.med.kyushu-u.ac.jp


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. Miyamoto, T. Matsumoto, H. Shiina, K. Inoue, I. Takada, S. Ito, J. Itoh, T. Minematsu, T. Sato, T. Yanase, et al.
The Pituitary Function of Androgen Receptor Constitutes a Glucocorticoid Production Circuit
Mol. Cell. Biol., July 1, 2007; 27(13): 4807 - 4814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Fan, T. Yanase, H. Morinaga, T. Okabe, M. Nomura, H. Daitoku, A. Fukamizu, S. Kato, R. Takayanagi, and H. Nawata
Insulin-like Growth Factor 1/Insulin Signaling Activates Androgen Signaling through Direct Interactions of Foxo1 with Androgen Receptor
J. Biol. Chem., March 9, 2007; 282(10): 7329 - 7338.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. A. Millward, J. D. Heaney, D. S. Sinasac, E. C. Chu, I. R. Bederman, D. A. Gilge, S. F. Previs, and C. M. Croniger
Mice With a Deletion in the Gene for CCAAT/Enhancer-Binding Protein {beta} Are Protected Against Diet-Induced Obesity
Diabetes, January 1, 2007; 56(1): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K B Lundin, Y L Giwercman, L Rylander, L Hagmar, and A Giwercman
Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men.
Eur. J. Endocrinol., August 1, 2006; 155(2): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. A. Albertelli, A. Scheller, M. Brogley, and D. M. Robins
Replacing the Mouse Androgen Receptor with Human Alleles Demonstrates Glutamine Tract Length-Dependent Effects on Physiology and Tumorigenesis in Mice
Mol. Endocrinol., June 1, 2006; 20(6): 1248 - 1260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.